Resource Center
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact UsLog InLog Out
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Equity Research
Research Reports
NeurAxis, Inc.
NeurAxis, Inc.
Reports
NeurAxis Reports Solid Second Quarter 2025 Results
August 13, 2025
KAREN STERLING, PhD, CFA
Download Report
NeurAxis Secures Key Academic Society Guidelines Recommendation for IB-Stim for Treatment of Functional Abdominal Pain
June 10, 2025
KAREN STERLING, PhD, CFA
Download Report
NeurAxis Announces FDA Clearance for IB-Stim Label Expansion to Pediatric Functional Dyspepsia, Nearly Doubling Its Total Addressable Market
May 21, 2025
KAREN STERLING, PhD, CFA
Download Report
NeurAxis Reports Strong First Quarter 2025 Results
May 13, 2025
KAREN STERLING, PhD, CFA
Download Report
Pioneering Neuromodulation: NeurAxis Offers a Non-Drug Alternative to Address Chronic and Debilitating Conditions in Children and Adults
March 31, 2025
KAREN STERLING, PhD, CFA
Download Report
Securities offered through Kingswood Capital Partners, LLC Member FINRA/SIPC. Advisory services offered through Kingswood Wealth Advisors an SEC registered investment advisor.
Kingswood USNews & MediaAbout UsLinkedInContact Us